A miracle. “Patients who take Voxzogo throughout childhood are likely to reach heights similar to their peers who don’t have achondroplasia”
U.S. FDA@US_FDA
Today, FDA approved a drug to improve growth in children five years of age and older who have achondroplasia and the potential to grow. Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth. fda.gov/news-events/pr…
English
